Scoping review identifies needed therapeutic strategies to improve clinical outcomes for Nipah virus infections.
Effective, clinically validated therapies for NiV infection are still lacking. Translational research, outbreak-ready clinical trial frameworks and prioritisation of promising therapeutic candidates are crucial for improving preparedness and clinical outcomes in future NiV outbreaks.
No takes yet. Share an insight, caveat, or question.
Kusuma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: